- Home
- CGC vs EICB Comparison
CGC vs EICB Comparison
Compare CGC & EICB Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- CGC
- EICB
- Stock Information
- Founded
- CGC N/A
- EICB N/A
- Country
- CGC Canada
- EICB
- Employees
- CGC N/A
- EICB N/A
- Industry
- CGC Pharmaceuticals and Biotechnology
- EICB
- Sector
- CGC Health Care
- EICB
- Exchange
- CGC Nasdaq
- EICB Nasdaq
- Market Cap
- CGC 431.7M
- EICB N/A
- IPO Year
- CGC N/A
- EICB N/A
- Fundamental
- Price
- CGC $1.36
- EICB $25.01
- Analyst Decision
- CGC Hold
- EICB
- Analyst Count
- CGC 1
- EICB 0
- Target Price
- CGC N/A
- EICB N/A
- AVG Volume (30 Days)
- CGC 22.2M
- EICB N/A
- Earning Date
- CGC 11-07-2025
- EICB N/A
- Dividend Yield
- CGC N/A
- EICB N/A
- EPS Growth
- CGC N/A
- EICB N/A
- EPS
- CGC N/A
- EICB N/A
- Revenue
- CGC $201,572,742.00
- EICB N/A
- Revenue This Year
- CGC $13.24
- EICB N/A
- Revenue Next Year
- CGC $3.68
- EICB N/A
- P/E Ratio
- CGC N/A
- EICB N/A
- Revenue Growth
- CGC N/A
- EICB N/A
- 52 Week Low
- CGC $0.77
- EICB N/A
- 52 Week High
- CGC $5.80
- EICB N/A
- Technical
- Relative Strength Index (RSI)
- CGC 48.50
- EICB 42.70
- Support Level
- CGC $1.35
- EICB $25.02
- Resistance Level
- CGC $1.52
- EICB $25.07
- Average True Range (ATR)
- CGC 0.14
- EICB 0.04
- MACD
- CGC -0.02
- EICB -0.01
- Stochastic Oscillator
- CGC 8.06
- EICB 12.00
About CGC Canopy Growth Corporation
Canopy Growth Corp, cultivates and sells medicinal and recreational cannabis and hemp through a portfolio of brands that include Doja, LivRelief, Ace Valley, Deep Space, and others. The Company is engaged in reportable segments namely: Canada cannabis, International markets cannabis, Storz & Bickel, and This Works. The company generates maximum revenue from Canadian cannabis.
About EICB Eagle Point Income Company Inc. 7.75% Series B Term Preferred Stock Due 2028
Eagle Point Income Co Inc is a closed-end management investment company. Its primary investment objective is to generate high current income, with a secondary objective to generate capital appreciation. The Company seeks to achieve its investment objectives by investing in junior debt tranches of collateralized loan obligations, or "CLOs," that are collateralized by a portfolio consisting of below-investment grade U.S. senior secured loans with a large number of distinct underlying borrowers across various industry sectors.